وبلاگ

Kloting N, P. Kovacs, M. Kern, J.T. Heiker, M. Fasshauer, M.R. Scho¨n, M. Stumvoll, A.G. Beck-Sickinger, M. Blu¨her, Central vaspin administration acutely reduces food intake and has sustained blood glucose-lowering effects. Diabetologia 54, 1819–۱۸۲۳ (۲۰۱۱).
Koiou E, K. Tziomalos, K. Dinas, I. Katsikis, E. Kalaitzakis, D. Delkos, E.A. Kandaraki, D. Panidis, (2011) The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome. Endocr. J., ۵۸, ۲۳۷–۲۴۶٫
Ko¨rner A, M. Neef, D. Friebe, S. Erbs, J. Kratzsch, K. Dittrich, S. Blu¨her, T.M. Kapellen, P. Kovacs, M. Stumvoll, M. Blu¨her, W. Kiess, (2011) Vaspin is related to gender, puberty and deteriorating insulin sensitivity in children. Int. J. Obes. (Lond), ۳۵, ۵۷۸–۵۸۶٫
Kukla M, et al. (2010) Chemerin, vaspin and insulin resistance in chronic hepatitis C. J. Viral. Hepat. 17:661–۷٫
Kukla M, et al. (2010) Serum chemerin and vaspin in nonalcoholic fatty liver disease. Scan. J. Gastroenterol. 45:235–۴۲٫
Kukla M, et al. (2011) Potential Role of Leptin, Adiponectin and Three Novel Adipokines—Visfatin, Chemerin and Vaspin—in Chronic Hepatitis.102119.
Kukla M, K. Zwirska-Korczala, A. Gabriel, M. Waluga, I. Warakomska, B. Szczygiel, A. Berdowska, W. Mazur, E. Wozniak- Grygiel, W. Kryczka, Chemerin, (2010) vaspin and insulin resistance in chronic hepatitis, C. J. Viral. Hepat. 17(9), 661–۶۶۷٫
Lehrke M, A. Becker, M. Greif, R. Stark, R.P. Laubender, F. von Ziegler, C. Lebherz, J. Tittus, M. Reiser, C. Becker, B. Goke, A.W. Leber, K.G. Parhofer, U.C. Broedl, (2009) Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. Eur. J. Endocrinol, 161(2), 339–۳۴۴٫
Lee J.A, H.S. Park, Y.S. Song, Y.J. Jang, J.H. Kim, Y.J. Lee, Y.S. Heo, (2011) Relationship between vaspin gene expression and abdominal fat distribution of Korean women. Endocr. J. ۸, ۶۳۹–۶۴۶٫
Legro RS. (2000) The genetics of obesity. Lessons for polycystic ovary syndrome. Ann NY Acad Sci, 900: 193-202.
Lin X, et al. (2012) Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with type 2 diabetes. 58(5-6):539-44.
Li Q, Chen R, Moriya J, Yamakawa J, Sumino H, Kanda T, et al. (2008) A novel adipocytokine, visceral adipose tissue-derived serine protease inhibitor (vaspin) and obesity. J Int Med Res, 36:625-9.
Li H.L, W.H. Peng, S.T. Cui, H. Lei, Y.D. Wei, W.M. Li, Y.W. Xu, (2011) Vaspin plasma concentrations and mRNA expressions in patients with stable and unstable angina pectoris. Clin. Chem. Lab. Med. ۴۹, ۱۵۴۷–۱۵۵۴٫
Loeffelholz C. von, M. Mo¨hlig, A.M. Arafat, F. Isken, J. Spranger, K. Mai, H.S. Randeva, A.F. Pfeiffer, M.O. Weickert, (2010) Circulating vaspin is unrelated to insulin sensitivity in a cohort of nondiabetic humans. Eur. J. Endocrinol. 162, 507–۵۱۳٫
MacDougald OA, Burant CF. (2007) The rapidly expanding family of adipokines. Cell Metabolism, 6: 159-61.
Mauras N, Del Giorno C, Kollman C, et al.(2010) Obesity without established comorbidities of the metabolic syndrome is associated with a proinflammatory and prothrombotic state, even before the onset of puberty in children. J Clin Endocrinol Metab, 95: 1060-8.
Muruganandan S, S.D. Parlee, J.L. Rourke, M.C. Ernst, K.B. Goralski, C.J. Sinal, Chemerin, (2011) a novel peroxisome proliferatoractivated receptor gamma (PPARgamma) target gene that promotes mesenchymal stem cell adipogenesis. J. Biol. Chem. ۲۸۶(۲۷), ۲۳۹۸۲–۲۳۹۹۵٫
Nakajima H, K. Nakajima, Y. Nagano, M. Yamamoto, M. Tarutani, M. Takahashi, Y. Takahashi, S. Sano, (2010) Circulating level of chemerin is upregulated in psoriasis. J. Dermatol. Sci. 60(1): 45–۴۷٫
Narita R, et al. (2004) Insulin resistance and insulin secretion in chronic hepatitis C virus infection. J. Hepatol. ۴۱: ۱۳۲–۸٫
Nagpal S, S. Patel, H. Jacobe, D. DiSepio, C. Ghosn, M. Malhotra, M. Teng, M. Duvic, R.A. (1997) Chandraratna, Tazaroteneinduced gene 2 (TIG2), a novel retinoid-responsive gene in skin. J. Invest. Dermatol. 109(1), 91–۹۵٫
Neitzel JJ. (2010) Enzyme Catalysis: The Serine Proteases. Nature Education, ۳: ۲۱٫
Nestler JE.(2008) Metformin for the treatment of the polycystic ovary syndrome. N Engl J Med, 358:47-54.
Oberbach A., K. Kirsch, S. Lehmann, N. Schlichting, M. Fasshauer, K. Zarse, M. Stumvoll, M. Ristow, M. Blu¨her, P. Kovacs, (2010) Serum vaspin concentrations are decreased after exercise-induced oxidative stress. Obes. Facts, 3, 328–۳۳۱٫
Olfat, G. Shaker, Nermin, Abdel Hamid Sadik, (2012) Vaspin gene in rat adipose tissue: relation to obesity-induced insulin resistance.
Ouchi N, Kihara S, Funahashi T, Nakamura T, Nishida M, Kumada M, et al. (2003) Reciprocal association of C-Reactive protein with adiponectin in blood stream and adipose tissue. Circulation,107:671-4.
Otero M. et al. (2005) Leptin, from fat to inflammation: old questions and new insights. FEBS Lett. 579, 295–۳۰۱٫
Parolini S, A. Santoro, E. Marcenaro, W. Luini, L. Massardi, F. Facchetti, D. Communi, M. Parmentier, A. Majorana, M. Sironi, G. Tabellini, A. Moretta, S. Sozzani, (2007) The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood, 109(9): 3625–۳۶۳۲٫
Phalitakul S, Okada M, Hara Y, Yamawaki H. (2011) Vaspin prevents TNF-α-induced intracellular adhesion molecule-1 via inhibiting reactive oxygen species-dependent NF-κB and PKCθ activation in cultured rat vascular smooth muscle cells. Pharmacol Res, 64: 493-500.
Potempa J, Korzus E, Travis J. (1994) The Serpin Superfamily of Proteinase Inhibitors: Structure, Function, and Regulation. J Biol Chem, 269:15957-60.
Rabe K, et al. (2008) Adipokines and insulin resistance. Mol. Med. 14:741–۵۱٫
Rico, H., Gervas, J.J., Hernandez, E.R., Seco, C., Villa, LF, Revilla, M.and Sanchez-Atrio, A., (1999) “Effects of alprazolam supplementation on vertebral and femoral bone mass in rats on strenuous treadmill training exercise". Calcified Tissue International, 65(2), 139-142.
Ristow M, K. Zarse, A. Oberbach, N. Klo¨ting, M. Birringer, M. Kiehntopf, M. Stumvoll, C.R. Kahn, M. Blu (2009) ¨her, Antioxidants prevent health-promoting effects of physical exercise in humans. Proc. Natl. Acad. Sci. USA 106, 8665–۸۶۷۰٫
Roh SG, Song SH, Choi KC, Katoh K, Wittamer V, Parmentier M, et al. (2007) Chemerin: a new adipokine that modulates adipogenesis via its own receptor. Biochem Biophys Res Commun, 362(4):1013-8.
Seeger J, et al. (2008) Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J. Clin. Endocrinol. Metab. 93:247–۵۱٫
Shimomura I, Funahashi T, Takahashi M, et al. (1996) Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med, ۲: ۸۰۰-۳٫
Shai I, D. Schwarzfuchs, Y. Henkin, D.R. Shahar, S. Witkow, I. Greenberg, R. Golan, D. Fraser, A. Bolotin, H. Vardi, O. Tangi- Rozental, R. Zuk-Ramot, B. Sarusi, D. Brickner, Z. Schwartz, E. Sheiner, R. Marko, E. Katorza, J. Thiery, G.M. Fiedler, M. Blu¨her, M.Stumvoll, M.J. Stampfer, (2008) Weight loss with a lowcarbohydrate, Mediterranean, or low-fat diet. N. Engl. J. Med. ۳۵۹, ۲۲۹–۲۴۱٫
Suwala A, et al. (2012) serum concentrations of chemerin, omentin-1 and vaspin in girls with anorexia nervosa. 29 P1295.
Soo Lim & Marie-France Hivert, (2012)Update on the Role of Adipokines in Atherosclerosis and Cardiovascular Diseases. 6: 53-61
Spiroglou S.G, C.G. Kostopoulos, J.N. Varakis, H.H. Papadaki, (2010) Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosis. J. Atheroscler. Thromb, 17: 115–۱۳۰٫
Stephan Schultz, Annette G, Beck Sickinger. (2012) Chemerin and vaspin: possible targets to treat obesity?, 10.1002.
Tan B.L, D. Heutling, J. Chen, S. Farhatullah, R. Adya, S.D. Keay, C.R. Kennedy, H. Lehnert, H.S. Randeva, (2008) Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes57, 1501–۱۵۰۷٫
Takahasi M, et al. (2008) Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS Lett. 582:573–۸٫
To¨njes A, M. Fasshauer, J. Kratzsch, M. Stumvoll, M. Blu (2010) ¨her, Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes. PLoS ONE ۵, e13911.
Trujillo ME, Scherer PE. (2000) Adipose tissue-derived factors: impact on health and disease. Endocr Rev, 627:762-78.
Vazquez Vela, M.E. et al. (2008) White adipose tissue as endocrine organ and its role in obesity. Arch. Med. Res. ۳۹, ۷۱۵–۷۲۸٫
Wada J. (2008) Vaspin: a novel serpin with insulin-sensitizing effects. Expert Opin. Investig. Drugs. ۱۷:۳۲۷–۳۳٫
Wajchenberg BL. Subcutaneous and Visceral Adipose (2000) Tissue: Their Relation to the Metabolic Syndrome. Endocrine Reviews, 21: 697-738.
Weigert J, M. Neumeier, J. Wanninger, M. Filarsky, S. Bauer, R. Wiest, S. Farkas, M.N. Scherer, A. Schaffler, C. Aslanidis, J. Scholmerich, C. Buechler, (2010) Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clin. Endocrinol. (Oxf) 72(3), 342–۳۴۸٫
Wittamer V, J.D. Franssen, M. Vulcano, J.F. Mirjolet, E. Le Poul, I. Migeotte, S.Brezillon, R. Tyldesley, C. Blanpain, M. Detheux, A. Mantovani, S. Sozzani, G. Vassart, M. Parmentier, D. Communi, (2003) Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J. Exp. Med. ۱۹۸(۷), ۹۷۷–۹۸۵٫
Wittamer V, F. Gregoire, P. Robberecht, G. Vassart, D. Communi, M. Parmentier, (2004) The C-terminal nonapeptide of mature chemerin activates the chemerin receptor with low nanomolar potency. J. Biol. Chem. 279(11), 9956–۹۹۶۲٫
Wittamer V, B. Bondue, A. Guillabert, G. Vassart, M. Parmentier, D. Communi, (2005) Neutrophil-mediated maturation of chemerin: a link between innate and adaptive immunity. J. Immunol. 175(1): 487–۴۹۳٫
Xiao Zhu, Yi Jiang, Peng-Fei Shan, Jie Shen, Qiu-Hua Liang, Rong-Rong Cui, Yuan Liu, Guan-Ying Liu, Shan-Shan Wu, Qiong Lu, Hui Xie, You-Shuo Liu, Ling-Qing Yuan, Er-Yuan Liao, (2012) Vaspin attenuates the apoptosis of human osteoblasts through ERK signaling pathway.